Chhavi Jain, Translational Programs Manager - Clinical Scientist on Influential Women

Influential Woman · Medical and Biotechnology

Chhavi Jain

Translational Programs Manager - Clinical Scientist, Roswell Park Comprehensive Cancer Center

Buffalo, NY

1Award received

Certifications · Degrees · Memberships

Degree PhD in Experimental Cancer Therapeutics Cert Project Management Professional (PMP) Member American Cancer Society Research HERS Initiative (Ambassador)

Her Story

About Chhavi

I’m a translational scientist and innovation strategist passionate about building platforms that bridge scientific discovery with scalable clinical impact. I earned my PhD in cancer biology from the Swiss Federal Institute of Technology in Switzerland, where training in a global research environment shaped both my scientific rigor and my cross-cultural perspective. Over the past decade, I’ve worked across cancer vaccines, cell and gene therapy, immunotherapy, and other advanced therapeutic modalities — leading complex translational oncology initiatives from early laboratory discovery into clinical trials.

One of the most defining experiences in my career was advancing a first-in-class breast cancer vaccine from preclinical development into human studies at the Cleveland Clinic. That journey required aligning scientific strategy, funding, cross-sector partnerships, and regulatory execution.

Today, at Roswell Park Comprehensive Cancer Center, I operate at the intersection of science, operations, and commercialization — structuring strategic partnerships, supporting regulatory pathways, and building the infrastructure that allows breakthrough therapies to reach patients faster and more equitably.

My work is driven by one goal: to create ecosystems where innovation doesn’t stall in the lab - it scales to real-world patient impact.




Her Interview

Ten minutes with Chhavi

01What do you attribute your success to?

I attribute my success to determination, the courage to think beyond conventional boundaries, and a strong bias toward action. I’ve never been afraid to step into complex spaces or take on challenges that didn’t have a clear roadmap. In translational science, progress often requires reimagining how disciplines connect - aligning research, regulation, funding, and partnerships in ways that haven’t been done before.

I also believe in being a “builder.” When I see a gap, I don’t wait for someone else to solve it - I step in, create structure, and move things forward. That combination of persistence, strategic thinking, and execution has shaped my journey.

02What’s the best career advice you’ve ever received?

I was once told, “Build quietly, build well - the right rooms will open.” That perspective shaped how I approached my career. I focused on learning deeply, contributing meaningfully, and delivering results. Over time, opportunities and visibility came as a natural extension of that foundation.

03What advice would you give to young women entering your industry?

Step outside your comfort zone early and often. Growth rarely happens in familiar spaces, and some of the most defining opportunities in my career came from saying yes before I felt completely ready.

Stay ambitious - but stay strategic. Ambition without direction can dilute your impact. Be intentional about where you invest your time, your energy, and your voice. Not every opportunity deserves your capacity.

Don’t be afraid to ask for help. Strength is not self-sufficiency; it’s knowing when collaboration accelerates progress.

And as your life becomes more multidimensional - as a professional, a mother, a partner, a daughter - energy becomes your most valuable resource. Protect it. Invest it where it aligns with your values and long-term vision.

Influence isn’t built by doing everything. It’s built by doing the right things well.

04What are the biggest challenges or opportunities in your field right now?

One of the most pressing challenges in translational science today is funding - particularly for academic research. Historically, some of the most transformative therapies have emerged from foundational work in academic laboratories. When funding tightens, early-stage innovation is often the first to feel the impact, and that can slow the pipeline of future breakthroughs.

But challenge and opportunity often coexist. Funding constraints are pushing the field to rethink traditional models - encouraging more strategic partnerships between academia and industry, more disciplined prioritization, and more creative approaches to advancing innovation with efficiency.

At the same time, we are at a remarkable inflection point with artificial intelligence. AI is accelerating target identification, biomarker discovery, trial design, and operational execution. Workstreams that once required years can now be compressed into months. Drug development is becoming more data-driven, predictive, and streamlined.

The opportunity ahead lies in integrating scientific rigor with technological acceleration - ensuring that as we move faster, we also move smarter and more equitably toward patient impact.

05What values are most important to you in your work and personal life?

Three values guide both my professional and personal life: integrity, excellence, and trust.

Integrity, to me, means alignment - ensuring that my decisions, especially under pressure, reflect my principles. In drug development and translational research, the stakes are high. These are complex, multi-million-dollar programs involving patients, regulators, industry partners, and academic leaders. Balancing speed, funding constraints, and expectations requires clarity of judgment. Integrity ensures that no matter how complex the environment, the foundation remains solid.

Excellence is not about perfection - it’s about rigor. It’s doing the hard thinking, preparing deeply, and holding myself to a standard that earns credibility. Over time, that discipline builds confidence within teams. I value being someone whose perspective is trusted because it is thoughtful, data-driven, and carefully considered.

Trust is both an outcome and a responsibility. It is built through consistency, transparency, and accountability. In cross-functional environments, trust is what allows innovation to move forward.

Ultimately, these values allow me to operate with confidence while remaining grounded - whether I’m leading complex programs or navigating the responsibilities of family and community.

Join Influential Women and start making an impact. Register now.